Nephrology News
Cytoreductive Nephrectomy Benefits for Metastatic RCC Demonstrated
Patients who underwent cytoreductive nephrectomy for metastatic non-clear cell renal cell carcinoma had a significantly decreased risk of cancer-related mortality.
By accepting you will be accessing a service provided by a third-party external to https://galencarepartners.com/